haloperidol has been researched along with Central Hypothyroidism in 16 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lithium carbonate is the single most important long-term treatment for recurrent affective disorders." | 4.76 | Lithium. ( DePaulo, JR, 1984) |
| " This diabetes insipidus is reversible, non-progressive, unrelated to plasma level, and distinct in attack from lithium-induced hypothyroidism, which may occur at low dosage but is also usually of late onset and reversible or treatable with thyroxine while lithium is continued." | 3.65 | Blood levels and management of lithium treatment. ( Crammer, JL; Crane, G; Rosser, RM, 1974) |
| "1." | 1.27 | Evidence for post-synaptic changes mediating increased behavioural sensitivity to dopamine receptor agonists in hypothyroid rats. ( Cameron, DL; Crocker, AD, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (75.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giné, E | 1 |
| Echeverry-Alzate, V | 1 |
| Lopez-Moreno, JA | 1 |
| Rodriguez de Fonseca, F | 1 |
| Perez-Castillo, A | 1 |
| Santos, A | 1 |
| Taskapan, C | 1 |
| Sahin, I | 1 |
| Taskapan, H | 1 |
| Kaya, B | 1 |
| Kosar, F | 1 |
| Gomez, J | 1 |
| Scott, G | 1 |
| Jahnke, G | 1 |
| Nicholson, G | 1 |
| Greeley, GH | 1 |
| Youngblood, WW | 1 |
| Prange, AJ | 1 |
| Kizer, JS | 1 |
| DePaulo, JR | 1 |
| Crocker, AD | 4 |
| Overstreet, DH | 3 |
| Lawson, CA | 1 |
| McIntosh, GH | 1 |
| Crocker, JM | 2 |
| Sowers, JR | 2 |
| Resch, G | 1 |
| Walker, S | 1 |
| Sollars, E | 2 |
| Delitala, G | 1 |
| Devilla, L | 1 |
| Canessa, A | 1 |
| D'Asta, F | 1 |
| Mizukami, M | 1 |
| Kishida, S | 1 |
| Hirai, M | 1 |
| Ooya, E | 1 |
| Nakai, T | 1 |
| Miyabo, S | 1 |
| Del Compare, JA | 1 |
| Aguirre, JA | 1 |
| Ibarra, FR | 1 |
| Barontini, M | 1 |
| Armando, I | 1 |
| Howard, JS | 1 |
| Cameron, DL | 1 |
| Crammer, JL | 1 |
| Rosser, RM | 1 |
| Crane, G | 1 |
1 review available for haloperidol and Central Hypothyroidism
| Article | Year |
|---|---|
Lithium.
Topics: Aggression; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, C | 1984 |
15 other studies available for haloperidol and Central Hypothyroidism
| Article | Year |
|---|---|
The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Brain; Cannabinoid Receptor Ago | 2017 |
Possible malignant neuroleptic syndrome that associated with hypothyroidism.
Topics: Adrenal Insufficiency; Antipsychotic Agents; Body Temperature; Clozapine; Female; Haloperidol; Human | 2005 |
Hypothyroidism, psychotropic drugs and cardiotoxicity.
Topics: Acute Disease; Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Hypothyroidism; Phenothiazi | 1980 |
Studies of the neural mechanisms by which hypothyroidism decreases prolactin secretion in the rat.
Topics: Animals; Caudate Nucleus; Dopamine; Haloperidol; Hypothalamo-Hypophyseal System; Hypothyroidism; Mal | 1980 |
Modification of the behavioural effects of haloperidol and of dopamine receptor regulation by altered thyroid status.
Topics: Animals; Behavior, Animal; Body Temperature; Catalepsy; Haloperidol; Humans; Hyperthyroidism; Hypoth | 1984 |
Alterations in the dopaminergic system and behaviour in rats reared on iodine-deficient diets.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Body Temperature; Body Weight; Brain Che | 1984 |
Developmental patterns of the hypothalamic-pituitary axis in the euthyroid and hypothyroid male rat.
Topics: Aging; Animals; Animals, Newborn; Gonadotropin-Releasing Hormone; Haloperidol; Hypothalamo-Hypophyse | 1980 |
Effect of rendering male rats hypothyroid at different stages of development on adenohypophysial hormone release.
Topics: Animals; Female; Haloperidol; Hypothyroidism; Luteinizing Hormone; Male; Pituitary Hormones, Anterio | 1980 |
On the role of dopamine receptors in the central regulation of human TSH.
Topics: Adult; Domperidone; Dopamine; Female; Haloperidol; Humans; Hypothalamus; Hypothyroidism; Male; Middl | 1981 |
[The effects of short and long duration of hypothyroidism on prolactin secretion in rats].
Topics: Animals; beta-Endorphin; Dopamine; Haloperidol; Hypothalamus; Hypothyroidism; Male; Pituitary Gland; | 1993 |
Effects of thyroid hormone on the renal dopaminergic system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antithyroid Agents; Benzazepines; Catechols; Dihydroxypheny | 2001 |
Somatic profiles in chronic schizophrenia.
Topics: Antipsychotic Agents; Chronic Disease; Folic Acid Deficiency; Haloperidol; Humans; Hypoglycemia; Hyp | 1976 |
Evidence for post-synaptic changes mediating increased behavioural sensitivity to dopamine receptor agonists in hypothyroid rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Brai | 1988 |
Hypothyroidism leads to increased dopamine receptor sensitivity and concentration.
Topics: Animals; Apomorphine; Body Temperature; Conditioning, Operant; Haloperidol; Hypothyroidism; Male; Ra | 1986 |
Blood levels and management of lithium treatment.
Topics: Administration, Oral; Adult; Aged; Carbimazole; Delayed-Action Preparations; Dementia; Depression; D | 1974 |